Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
NCT06965374
·
clinicaltrials.gov ↗
RECRUITING
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Sponsor
AbbVie